S&P 500   2,966.15 (-0.14%)
DOW   26,787.36 (-0.11%)
QQQ   191.09 (-0.01%)
AAPL   235.87 (-0.14%)
FB   183.28 (-0.49%)
MSFT   139.55 (-0.09%)
GOOGL   1,217.77 (+0.17%)
AMZN   1,736.43 (+0.26%)
CGC   18.86 (-2.93%)
NVDA   186.53 (+0.29%)
MU   44.86 (-0.53%)
BABA   171.16 (-1.03%)
T   37.47 (-0.29%)
F   8.82 (+0.46%)
ACB   3.51 (-4.62%)
PRI   121.47 (-0.18%)
NFLX   285.53 (+0.92%)
GILD   64.51 (+0.81%)
DIS   129.70 (-0.25%)
S&P 500   2,966.15 (-0.14%)
DOW   26,787.36 (-0.11%)
QQQ   191.09 (-0.01%)
AAPL   235.87 (-0.14%)
FB   183.28 (-0.49%)
MSFT   139.55 (-0.09%)
GOOGL   1,217.77 (+0.17%)
AMZN   1,736.43 (+0.26%)
CGC   18.86 (-2.93%)
NVDA   186.53 (+0.29%)
MU   44.86 (-0.53%)
BABA   171.16 (-1.03%)
T   37.47 (-0.29%)
F   8.82 (+0.46%)
ACB   3.51 (-4.62%)
PRI   121.47 (-0.18%)
NFLX   285.53 (+0.92%)
GILD   64.51 (+0.81%)
DIS   129.70 (-0.25%)
Log in

Davita Stock Price, News & Analysis (NYSE:DVA)

$55.67
-0.77 (-1.36 %)
(As of 10/14/2019 04:00 PM ET)
Today's Range
$55.60
Now: $55.67
$56.40
50-Day Range
$54.23
MA: $57.72
$63.41
52-Week Range
$43.40
Now: $55.67
$79.11
Volume843,203 shs
Average Volume2.06 million shs
Market Capitalization$8.92 billion
P/E Ratio15.59
Dividend YieldN/A
Beta1.6
DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. Read More…

Industry, Sector and Symbol

Industry Miscellaneous health & allied services, not elsewhere classified
Sub-IndustryHealth Care Services
SectorMedical
CUSIP23918K10
Phone720-631-2100

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$11.40 billion
Cash Flow$7.25 per share
Book Value$23.55 per share

Profitability

Net Income$159.39 million

Miscellaneous

Employees77,700
Market Cap$8.92 billion
Next Earnings Date11/6/2019 (Estimated)
OptionableOptionable

Receive DVA News and Ratings via Email

Sign-up to receive the latest news and ratings for DVA and its competitors with MarketBeat's FREE daily newsletter.


Davita (NYSE:DVA) Frequently Asked Questions

What is Davita's stock symbol?

Davita trades on the New York Stock Exchange (NYSE) under the ticker symbol "DVA."

How were Davita's earnings last quarter?

Davita Inc (NYSE:DVA) released its earnings results on Thursday, August, 1st. The company reported $1.22 earnings per share for the quarter, beating analysts' consensus estimates of $1.10 by $0.12. The company had revenue of $2.84 billion for the quarter, compared to analysts' expectations of $2.86 billion. Davita had a net margin of 1.21% and a return on equity of 14.67%. Davita's revenue for the quarter was down 1.5% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.05 EPS. View Davita's Earnings History.

When is Davita's next earnings date?

Davita is scheduled to release their next quarterly earnings announcement on Wednesday, November 6th 2019. View Earnings Estimates for Davita.

What price target have analysts set for DVA?

8 brokers have issued 1 year target prices for Davita's shares. Their forecasts range from $60.00 to $70.00. On average, they expect Davita's share price to reach $65.35 in the next twelve months. This suggests a possible upside of 17.4% from the stock's current price. View Analyst Price Targets for Davita.

What is the consensus analysts' recommendation for Davita?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Davita in the last year. There are currently 6 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Davita.

Has Davita been receiving favorable news coverage?

News articles about DVA stock have been trending negative on Monday, according to InfoTrie Sentiment. The research firm identifies positive and negative news coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Davita earned a news impact score of -2.8 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the stock's share price in the near future. View News Stories for Davita.

Are investors shorting Davita?

Davita saw a drop in short interest during the month of September. As of September 30th, there was short interest totalling 10,930,000 shares, a drop of 16.8% from the August 30th total of 13,130,000 shares. Based on an average daily trading volume, of 3,100,000 shares, the short-interest ratio is presently 3.5 days. Approximately 7.1% of the shares of the stock are short sold. View Davita's Current Options Chain.

Who are some of Davita's key competitors?

What other stocks do shareholders of Davita own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Davita investors own include CA (CA), BlackRock (BLK), Endologix (ELGX), Chipotle Mexican Grill (CMG), Aegean Marine Petroleum Network (ANW), AutoZone (AZO), Micron Technology (MU), Designer Brands (DBI), Precision Drilling (PD) and United Rentals (URI).

Who are Davita's key executives?

Davita's management team includes the folowing people:
  • Mr. Kent J. Thiry, Chairman & CEO (Age 63)
  • Mr. Joel Ackerman, Chief Financial Officer (Age 54)
  • Mr. James K. Hilger, Chief Accounting Officer (Age 57)
  • Ms. Kathleen Alyce Waters, Chief Legal Officer (Age 51)
  • Mr. Javier J. Rodriguez, Chief Exec. Officer of DaVita Kidney Care (Age 48)

Who are Davita's major shareholders?

Davita's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Crossmark Global Holdings Inc. (0.02%), State of Alaska Department of Revenue (0.01%), Rothschild Investment Corp IL (0.01%), Pacer Advisors Inc. (0.01%), Stonebridge Capital Management Inc. (0.01%) and Lau Associates LLC (0.01%). Company insiders that own Davita stock include Charles Berg, James K Hilger, Javier Rodriguez, Kent J Thiry, Leanne M Zumwalt, Pamela M Arway and William L Roper. View Institutional Ownership Trends for Davita.

Which institutional investors are selling Davita stock?

DVA stock was sold by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue, Lau Associates LLC, Stonebridge Capital Management Inc., Crossmark Global Holdings Inc. and Pacer Advisors Inc.. View Insider Buying and Selling for Davita.

Which institutional investors are buying Davita stock?

DVA stock was bought by a variety of institutional investors in the last quarter, including Rothschild Investment Corp IL and North Star Investment Management Corp.. View Insider Buying and Selling for Davita.

How do I buy shares of Davita?

Shares of DVA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Davita's stock price today?

One share of DVA stock can currently be purchased for approximately $55.67.

How big of a company is Davita?

Davita has a market capitalization of $8.92 billion and generates $11.40 billion in revenue each year. The company earns $159.39 million in net income (profit) each year or $3.57 on an earnings per share basis. Davita employs 77,700 workers across the globe.View Additional Information About Davita.

What is Davita's official website?

The official website for Davita is http://www.davita.com/.

How can I contact Davita?

Davita's mailing address is 2000 16TH STREET, DENVER CO, 80202. The company can be reached via phone at 720-631-2100 or via email at [email protected]


MarketBeat Community Rating for Davita (NYSE DVA)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  418 (Vote Outperform)
Underperform Votes:  468 (Vote Underperform)
Total Votes:  886
MarketBeat's community ratings are surveys of what our community members think about Davita and other stocks. Vote "Outperform" if you believe DVA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe DVA will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/14/2019 by MarketBeat.com Staff

Featured Article: Retained Earnings

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel